We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 107 results
  1. Adiponectin receptor 1-mediated stimulation of Cav3.2 channels in trigeminal ganglion neurons induces nociceptive behaviors in mice

    Background

    Adipokines, including adiponectin, are implicated in nociceptive pain; however, the underlying cellular and molecular mechanisms remain...

    Yuan Zhang, Yuan Wei, ... ** Tao in The Journal of Headache and Pain
    Article Open access 25 August 2023
  2. Titin and CK2α are New Intracellular Targets in Acute Insulin Application-Associated Benefits on Electrophysiological Parameters of Left Ventricular Cardiomyocytes From Insulin-Resistant Metabolic Syndrome Rats

    Background

    Previous studies have demonstrated that a high-carbohydrate intake could induce metabolic syndrome (MetS) in male rats with marked cardiac...

    Aysegul Durak, Ceylan V. Bitirim, Belma Turan in Cardiovascular Drugs and Therapy
    Article 06 May 2020
  3. Small molecule induces mitochondrial fusion for neuroprotection via targeting CK2 without affecting its conventional kinase activity

    Mitochondrial fusion/fission dynamics plays a fundamental role in neuroprotection; however, there is still a severe lack of therapeutic targets for...

    Ke-Wu Zeng, **g-Kang Wang, ... Pengfei Tu in Signal Transduction and Targeted Therapy
    Article Open access 19 February 2021
  4. Regulation of cancer progression by CK2: an emerging therapeutic target

    Casein kinase II (CK2) is an enzyme with pleiotropic kinase activity that catalyzes the phosphorylation of lots of substrates, including STAT3, p53,...

    Shakeel Hussain, Yilei Guo, ... Yongzhong Hou in Medical Oncology
    Article 25 March 2024
  5. CK2 activity is crucial for proper glucagon expression

    Aims/hypothesis

    Protein kinase CK2 acts as a negative regulator of insulin expression in pancreatic beta cells. This action is mainly mediated by...

    Emmanuel Ampofo, Mandy Pack, ... Claudia Götz in Diabetologia
    Article Open access 20 March 2024
  6. Targeting CK2-mediated phosphorylation of p53R2 sensitizes BRCA-proficient cancer cells to PARP inhibitors

    Poly[ADP-ribose] polymerase (PARP) inhibitors, which selectively kills homologous recombination (HR) repair-deficient cancer cells, are widely...

    Cong Wang, Ling Tian, ... Guo Chen in Oncogene
    Article 24 August 2023
  7. Roles of NOLC1 in cancers and viral infection

    Background

    The nucleolus is considered the center of metabolic control and an important organelle for the biogenesis of ribosomal RNA (rRNA)....

    Fengguang Zhai, Jie Wang, ... **aofeng ** in Journal of Cancer Research and Clinical Oncology
    Article 09 June 2023
  8. Hypoxia switches TET1 from being tumor-suppressive to oncogenic

    The classical oxidizing enzymatic activity of Ten Eleven Translocation 1 (TET1) and its tumor suppressor role are well known. Here, we find that high...

    Qi Yang, Hui Dang, ... Peng Hou in Oncogene
    Article Open access 05 April 2023
  9. P21-activated kinase 1 (PAK1)-mediated cytoskeleton rearrangement promotes SARS-CoV-2 entry and ACE2 autophagic degradation

    Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of coronavirus disease 2019 (COVID-19), has had a significant...

    Ming Liu, Bingtai Lu, ... Yuxia Zhang in Signal Transduction and Targeted Therapy
    Article Open access 09 October 2023
  10. Anti-tumor effect of avadomide in gemcitabine-resistant pancreatic ductal adenocarcinoma

    Purpose

    Although gemcitabine-based chemotherapy is most recommended for pancreatic ductal adenocarcinoma (PDAC), its effectiveness is limited because...

    Hidemi Nishi, Kunihito Gotoh, ... Hidetoshi Eguchi in Cancer Chemotherapy and Pharmacology
    Article Open access 26 July 2023
  11. Mitophagy for cardioprotection

    Mitochondrial function is maintained by several strictly coordinated mechanisms, collectively termed mitochondrial quality control mechanisms,...

    Allen Sam Titus, Eun-Ah Sung, ... Junichi Sadoshima in Basic Research in Cardiology
    Article Open access 05 October 2023
  12. RETRACTED ARTICLE: NR4A1 aggravates the cardiac microvascular ischemia reperfusion injury through suppressing FUNDC1-mediated mitophagy and promoting Mff-required mitochondrial fission by CK2α

    Mitochondrial fission and mitophagy are considered key processes involved in the pathogenesis of cardiac microvascular ischemia reperfusion (IR)...

    Hao Zhou, ** Wang, ... Yundai Chen in Basic Research in Cardiology
    Article 09 May 2018
  13. The protein kinase CK2 contributes to the malignant phenotype of cholangiocarcinoma cells

    Cholangiocarcinoma (CCA) is a particularly aggressive hepatobiliary malignancy, for which the molecular mechanisms underlying the malignant phenotype...

    Giovanni Di Maira, Alessandra Gentilini, ... Fabio Marra in Oncogenesis
    Article Open access 22 October 2019
  14. Protein kinase CK2: a potential therapeutic target for diverse human diseases

    CK2 is a constitutively active Ser/Thr protein kinase, which phosphorylates hundreds of substrates, controls several signaling pathways, and is...

    Christian Borgo, Claudio D’Amore, ... Maria Ruzzene in Signal Transduction and Targeted Therapy
    Article Open access 17 May 2021
  15. Two different presentations of de novo variants of CSNK2B: two case reports

    Background

    Poirier–Bienvenu neurodevelopmental syndrome is a neurologic disorder caused by mutations in the CSNK2B gene. It is mostly characterized...

    Matheus V. M. B Wilke, Bibiana M. Oliveira, ... Carolina F. M. Souza in Journal of Medical Case Reports
    Article Open access 05 January 2022
  16. CircNDST1 promotes papillary thyroid cancer progression via its interaction with CSNK2A1 to activate the PI3K–Akt pathway and epithelial–mesenchymal transition

    Background

    Multiple studies have established a strong relationship between circRNA and cancer progression. Cervical lymph node metastasis is a key...

    C. Shu, S. Wang, ... T. Huang in Journal of Endocrinological Investigation
    Article Open access 28 October 2022
  17. Dual targeting of MTOR as a novel therapeutic approach for high-risk B-cell acute lymphoblastic leukemia

    Children of Hispanic/Latino ancestry have increased incidence of high-risk B-cell acute lymphoblastic leukemia (HR B-ALL) with poor prognosis. This...

    Zheng Ge, Chunhua Song, ... Sinisa Dovat in Leukemia
    Article Open access 02 February 2021
  18. Resistance to BET inhibitors in lung adenocarcinoma is mediated by casein kinase phosphorylation of BRD4

    Targeting the epigenome to modulate gene expression programs driving cancer development has emerged as an exciting avenue for therapeutic...

    Jack Calder, Amy Nagelberg, ... William W. Lockwood in Oncogenesis
    Article Open access 12 March 2021
  19. Histone N-terminal acetyltransferase NAA40 links one-carbon metabolism to chemoresistance

    Aberrant function of epigenetic modifiers plays an important role not only in the progression of cancer but also the development of drug resistance....

    Christina Demetriadou, Anastasia Raoukka, ... Antonis Kirmizis in Oncogene
    Article Open access 16 November 2021
Did you find what you were looking for? Share feedback.